Načítá se...
Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 β-lactamases: Raman crystallographic evidence
Tazobactam, sulbactam, and clavulanic acid are the only β-lactamase inhibitors in clinical use. Comparative inhibitory activities of clavulanic acid, sulbactam, and tazobactam against clinically important β-lactamases conclude that tazobactam is superior to both clavulanic acid and sulbactam. Thus f...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2661619/ https://ncbi.nlm.nih.gov/pubmed/19161282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ja808311s |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|